Changshan Pharmaceutical (Hongkong) Limited Company Information

Current Status : Live


Changshan Pharmaceutical (Hongkong) Limited's Hong Kong CR Number is 2140971. Incorporation Date is 04-SEP-2014. It's Winding up Mode is . Dissolution date is . Changshan Pharmaceutical (Hongkong) Limited company is of Private company limited by shares Type.
Additional Remarks on the Changshan Pharmaceutical (Hongkong) Limited company are .

Company Data

CRN2140971
Company NameChangshan Pharmaceutical (HongKong) Limited
Chinese Name常山藥業(香港)有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation04-SEP-2014
See companies with same Incorporation Date - 04-SEP-2014
Date of Dissolution
Remarks
Important Note
Tagspharmaceutical   changshan   hongkong   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
Changshan Pharmaceutical (HongKong) Limited04-SEP-2014

FAQs:

When was Changshan Pharmaceutical (Hongkong) Limited incorporated?

Changshan Pharmaceutical (Hongkong) Limited was incorporated on 04-SEP-2014 in Hongkong.

What is the type of Changshan Pharmaceutical (Hongkong) Limited?

Changshan Pharmaceutical (Hongkong) Limited is classified as Private company limited by shares.

What is the current status of Changshan Pharmaceutical (Hongkong) Limited Company?

The status of Changshan Pharmaceutical (Hongkong) Limited is Live.

What is the CR Number of Changshan Pharmaceutical (Hongkong) Limited?

The CR Number of Changshan Pharmaceutical (Hongkong) Limited is 2140971.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Changshan Pharmaceutical (Hongkong) Limited. The official registry should always be referred for latest information.

Last Updated on 25-06-2016.

Check other companies added on 25-06-2016

Check out Companies Incorporated on 04-SEP-2014: